An investor reports a Varex Imaging (VREX) stake with voting power over 1.02M shares.
Pzena Investment Management, LLC has reported a 4.2% passive stake in Varex Imaging Corp (VREX) through an SEC SCHEDULE 13G/A filing. The firm's clients beneficially own 1,785,166 shares, with Pzena holding sole voting power over 1,020,770 shares and sole dispositive power over 1,785,166 shares. This filing indicates that clients retain dividend and sale proceeds rights, with no single client holding more than 5% interest in the class.
Lobbying Update: $30,000 of VAREX IMAGING CORPORATION lobbying was just disclosed
Varex Imaging Corporation (VREX) disclosed $30,000 in lobbying expenses for Q3 2026, primarily focused on the "Promotion of high energy X-ray systems for CBP Non-intrusive inspection." The article also details recent insider trading activity, showing two sales by officers totaling over $2.5 million, and significant hedge fund activity with both additions and removals of VREX shares in Q2 2026.
VREXV5053657 Bond Profile: Coupon and Redemption
This article provides a detailed profile of the VREXV5053657 bond issued by Varex Imaging Corporation. It covers key information such as the issuer's details, issue and maturity dates, face value, coupon rate, and payment schedule. The bond has a fixed rate of 7.88% with semi-annual payments and matures on October 15, 2027.
Varex Imaging Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Varex Imaging Corporation - VREX
Kahn Swick & Foti, LLC (KSF) is investigating the proposed sale of Varex Imaging Corporation (NasdaqGS: VREX) to Teledyne Technologies Incorporated (NYSE: TDY) for $18.90 per share in cash. KSF aims to determine if this consideration adequately values Varex Imaging and if the process leading to the sale was fair. Shareholders who believe the offer undervalues the company are encouraged to contact KSF to discuss their legal rights.
VREX: Varex Imaging Corp Latest Stock Price, Analysis, News and Trading Ideas
This page provides the latest stock price, analysis, news, and trading ideas for Varex Imaging Corp (VREX). As of the article's time, VREX closed at $18.47 with a slight daily increase of 0.11%. The platform also indicates a bearish sentiment among users.
Varex Imaging (NASDAQ: VREX) director trims stake, now holds 15,329 shares
Varex Imaging Corp (VREX) director Jay K. Kunkel sold 8,121 shares of common stock on September 14, 2026, at $18.48 per share. Following this transaction, Kunkel directly holds 15,329 shares. The sale was an open-market or private transaction and was not conducted under a Rule 10b5-1 trading plan.
Insider Move: Shubham Maheshwari Exercises Options, Realizing $783K At Varex Imaging
Shubham Maheshwari, CFO at Varex Imaging (NASDAQ: VREX), exercised stock options for 160,944 shares worth $783,797, according to a recent SEC filing. The article highlights Varex Imaging's financial health, including its revenue growth, profitability, debt management, and valuation metrics. It also explains the significance of insider transactions for investors.
Varex Imaging director Kunkel sells $150k in shares
Jay K. Kunkel, a director at Varex Imaging Corp (NASDAQ:VREX), sold 8,121 shares of the company's common stock for a total of $150,076 on September 14, 2026. Following this transaction, Kunkel beneficially owns 15,329 shares. The sale occurred while VREX trades near its 52-week high after a 61% gain over the past year, with InvestingPro analysis indicating the stock is currently overvalued.
Varex Imaging Director Jay K. Kunkel Sells 8,121 Shares at $18.48 Each
Varex Imaging Corp Director Jay K. Kunkel sold 8,121 shares of the company's common stock at $18.48 per share on September 14, 2026. This transaction was reported in a Form 4 filing with the SEC on September 15, 2026. Following the sale, Kunkel retains direct ownership of 15,329 shares of Varex Imaging.
Varex Imaging CFO sells $2.4m in stock after option exercise
Shubham Maheshwari, CFO of Varex Imaging Corp, sold 130,000 shares for approximately $2.4 million after exercising stock options. This "sell-to-cover" transaction occurred as the stock traded near its 52-week high following a significant surge, despite InvestingPro's analysis suggesting it is slightly overvalued. Following these transactions, Maheshwari directly holds 139,972 shares.
Varex Imaging (NASDAQ: VREX) filer plans $2.4M stock sale
A recent SEC Form 144 filing indicates that Shubham Maheshwari, a holder of Varex Imaging (VREX), plans to sell 130,000 common shares through Fidelity Brokerage Services LLC. The sale, valued at approximately $2.4 million, is tied to a stock option exercise with an expected transaction date of September 11, 2026. This notice provides transparency regarding potential insider activity and the upcoming entry of these shares into the market.
Why Is Varex Imaging Stock Soaring Monday? - Teledyne Technologies (NYSE:TDY), Varex Imaging (NASDAQ:VREX
Varex Imaging (NASDAQ: VREX) shares surged over 48% after Teledyne Technologies Inc. (NYSE: TDY) announced its agreement to acquire Varex for $1.1 billion in an all-cash transaction. This acquisition aims to expand Teledyne's presence in medical and industrial X-ray imaging, complementing their existing product portfolios. The deal, which has been unanimously approved by both boards, is expected to close in early 2027 and follows Varex's recent strong quarterly earnings report.
Varex Imaging Corp (VI4.SG) Stock Price, News, Quote & History
This article provides the stock price, news, quote, and history for Varex Imaging Corp (VI4.SG) on Yahoo Finance. It displays current market data, including the stock price and daily change, and offers links to various financial analysis tools like income statements, balance sheets, and dividend information.
Should Value Investors Buy VAREX IMAGING (VREX) Stock?
Zacks Investment Research recommends VAREX IMAGING (VREX) as a strong value stock due to its favorable Zacks Rank #2 (Buy) and "A" grade for Value. The article highlights VREX's attractive valuation metrics, including a P/E ratio of 12.78, a P/B ratio of 1.08, and a P/S ratio of 0.9, all of which are lower than its industry averages. These indicators suggest that VREX is currently undervalued and possesses a strong earnings outlook.
Pzena Investment Management LLC Invests $45.31 Million in Varex Imaging $VREX
Pzena Investment Management LLC has acquired a new stake of 4.34 million shares in Varex Imaging (NASDAQ:VREX), valued at approximately $45.31 million, making it a 10.32% owner of the company. Despite Varex beating earnings per share estimates, its revenue fell short, and analysts currently have a cautious "Reduce" rating with a target price below its current trading price. Several other institutional investors also adjusted their holdings in Varex Imaging during recent quarters.
Varex Imaging (NASDAQ: VREX) outlines RSU vesting and tax-share withholding for HR chief
Varex Imaging Corp's Chief Human Resources Officer, Karen L. Aranki, had 3,974 Restricted Stock Units (RSUs) vest on August 14, 2026. From these, 1,145 shares were withheld at $18.49 per share to cover tax obligations. Aranki now holds 3,975 remaining RSUs, with future vesting dates in 2026 and 2028.
Varex Imaging Corporation News | VREX Real-time News & Related Reports
This article provides an overview of Varex Imaging Corporation (VREX), including its current stock price, market capitalization, P/E ratio, and recent trading activity. It also lists various financial data points and indicates that the news and data are for reference only, not investment advice.
Rice Hall James & Associates LLC Purchases New Position in Varex Imaging $VREX
Rice Hall James & Associates LLC has acquired a new position in Varex Imaging (NASDAQ:VREX), purchasing 1.45 million shares valued at approximately $15.1 million, representing a 3.43% stake. Despite this acquisition and Varex Imaging exceeding quarterly EPS estimates, analyst sentiment remains cautious with a "Reduce" consensus rating and a target price of $16.88. Several other institutional investors also adjusted their holdings in the company during recent quarters.
Varex Imaging (NASDAQ:VREX) Receives Consensus Recommendation of "Reduce" from Brokerages
Varex Imaging (NASDAQ:VREX) has received a consensus "Reduce" rating from seven brokerages, with one sell rating and six hold ratings, and an average 12-month price target of $16.875. This comes despite recent positive institutional activity and quarterly earnings that beat consensus estimates, though revenue fell short. Several firms, including Zacks Research and Oppenheimer, have recently downgraded their ratings on the stock.
Varex Imaging (NASDAQ:VREX) Stock Rating Lowered by CJS Securities
CJS Securities downgraded Varex Imaging (NASDAQ:VREX) from an "outperform" to a "market perform" rating. This downgrade aligns with other analysts who have issued "hold" or "sell" ratings, resulting in an average "Reduce" rating and a $16.88 consensus price target for the stock. Despite exceeding Q3 EPS estimates with $0.31, revenue of $210.5 million missed the $215.5 million consensus, and the company projects full-year EPS of $0.93.
Teledyne to Acquire Varex Imaging Corporation
Teledyne Technologies Incorporated announced its definitive agreement to acquire Varex Imaging Corporation for approximately $1.1 billion, or $18.90 per share in cash. Varex specializes in X-ray sources and digital X-ray detectors for various applications, complementing Teledyne's existing healthcare market presence with minimal product overlap. The acquisition is expected to close in early 2027, subject to regulatory and stockholder approvals.
Assenagon Asset Management S.A. Sells 372,475 Shares of Varex Imaging $VREX
Assenagon Asset Management S.A. significantly reduced its stake in Varex Imaging (NASDAQ:VREX) by 80.6% in the second quarter, selling 372,475 shares and retaining 89,412 shares valued at $933,000. This move contrasts with other institutional investors like LSV Asset Management, Millennium Management, and Qube Research & Technologies, which increased their positions. Despite Varex Imaging beating EPS expectations, the stock holds a consensus "Reduce" rating and an average price target of $16.88 from analysts, indicating mixed sentiment and cautious outlook.
VAREX IMAGING (VREX) Q3 Earnings Beat Estimates
VAREX IMAGING (VREX) reported Q3 earnings of $0.31 per share, surpassing the Zacks Consensus Estimate of $0.22 per share, and revenues of $210.5 million, which missed the estimate. Despite the earnings beat, the company's shares have underperformed the S&P 500 year-to-date. The stock currently holds a Zacks Rank #3 (Hold) based on mixed estimate revisions.
Varex Imaging Corporation Stock 12‑Month Price Target Cut to $17.58, Implies 42% Upside
The average 12-month price target for Varex Imaging Corporation (VREX) stock has been lowered from $18 to $17.58 by 5 analysts, with individual forecasts ranging from $12 to $20 per share. This new target suggests a potential upside of approximately 42% from its August 7 closing price. The consensus rating among the 5 covering analysts remains "Buy," comprising 2 Buys and 3 Holds.
Teledyne to Acquire Varex Imaging for $1.1 Billion in Cash, Adding Oncology X-Ray Tech
Teledyne Technologies announced its acquisition of Varex Imaging for $1.1 billion in an all-cash deal, paying $18.90 per share, a premium of over 50%. This strategic move expands Teledyne's X-ray portfolio by adding oncology-grade detectors and advanced photon-counting technology. The transaction, unanimously approved by both boards, is expected to close in early 2027, subject to regulatory and shareholder approvals.
Varex Imaging Agrees to Teledyne All-Cash Acquisition
Varex Imaging has agreed to be acquired by Teledyne Technologies in an all-cash deal valued at approximately $1.1 billion. The acquisition, pending shareholder and regulatory approvals, will result in Varex becoming a wholly-owned subsidiary of Teledyne and its delisting from Nasdaq in early 2027. This merger aims to strengthen Teledyne's position in medical imaging and industrial inspection by integrating Varex's X-ray tubes and photon-counting detectors with Teledyne's existing portfolio.
Teledyne to acquire Varex in $1.1 billion deal
Teledyne Technologies (NYSE: TDY) has announced its intent to acquire Varex Imaging Corporation (NASDAQ: VREX) for approximately $1.1 billion in cash, paying $18.90 per share. This acquisition will expand Teledyne's healthcare market presence with Varex's complementary X-ray sources and digital detectors, which are used in medical diagnostic imaging, security, and industrial applications. The transaction, unanimously approved by both boards, is expected to close in early 2027, pending regulatory and Varex stockholder approvals.
Teledyne inks $1.1B takeover of Varex Imaging
Teledyne Technologies announced its acquisition of Varex Imaging for approximately $1.1 billion. This strategic move aims to expand Teledyne's presence in the healthcare market by integrating Varex's X-ray imaging components and products, which are complementary to Teledyne's existing digital imaging portfolio with minimal overlap. The deal, which requires regulatory approval, is expected to close early next year, further contributing to the high M&A activity in the medtech sector.
Teledyne to acquire Varex Imaging in $1.1B deal
Teledyne Technologies is set to acquire Varex Imaging for approximately $1.1 billion, integrating Varex's X-ray tubes and digital detectors into Teledyne's medical imaging portfolio. This strategic move aims to complement Teledyne's existing imaging technologies, particularly in areas like high-radiation environments and advanced photon-counting detectors. The transaction, unanimously approved by both boards, is expected to close in early 2027, pending regulatory and shareholder approvals, though some investors are reportedly considering litigation over the sale price.
Teledyne to acquire Varex Imaging in $1.1 billion deal
Teledyne Technologies announced its agreement to acquire Varex Imaging Corporation for approximately $1.1 billion. This acquisition will significantly expand Teledyne's medical and industrial X-ray imaging portfolio by adding Varex's X-ray tubes, digital X-ray detectors, and advanced photon-counting detectors. The deal, representing an 88% premium over Varex's stock price in late May 2026, is expected to close in early 2027, pending regulatory and shareholder approvals.
Varex Imaging downgraded to Neutral from Buy at B. Riley
B. Riley downgraded Varex Imaging (VREX) to Neutral from Buy, increasing the price target slightly to $18.90 from $18.00. This change comes after Varex Imaging agreed to be acquired by Teledyne Technologies for $18.90 per share in cash, leaving limited upside potential without a competing offer.
Teledyne to acquire Varex Imaging (VREX) in $1.1B all‑cash merger deal
Teledyne Technologies will acquire Varex Imaging (VREX) in an all-cash merger deal valued at approximately $1.1 billion, including equity awards and net debt. Varex shareholders will receive $18.90 per share, and the transaction is expected to close in early 2027, subject to regulatory and stockholder approvals. The acquisition aims to complement Teledyne's existing healthcare and industrial imaging portfolio without significant product overlap.
Varex Imaging Posts Upbeat Q3 Earnings, Joins Bowman Consulting, MarineMax And Other Big Stocks Moving Hi
Varex Imaging Corp (NASDAQ: VREX) saw its shares jump 48.4% after reporting better-than-expected Q3 earnings, beating analyst estimates for EPS but missing on sales. The company also announced it would be acquired by Teledyne. Several other companies, including Bowman Consulting Group Ltd, MarineMax Inc, and AbCellera Biologics Inc, also experienced significant stock gains due to positive financial results or acquisition news.
Teledyne to Acquire Varex Imaging Corporation
Teledyne Technologies Incorporated announced it will acquire Varex Imaging Corporation for approximately $1.1 billion, or $18.90 per share in cash. This acquisition will expand Teledyne's presence in the healthcare and industrial imaging markets by integrating Varex's X-ray sources and digital detectors, which are complementary to Teledyne's existing product portfolio. The transaction, unanimously approved by both boards, is expected to close in early 2027, pending regulatory and stockholder approvals.
Teledyne to acquire Varex Imaging for $1.1 billion in cash
Teledyne Technologies Incorporated announced its definitive agreement to acquire Varex Imaging Corporation for $1.1 billion in cash, including equity awards and net debt. The deal, unanimously approved by both boards, will see Teledyne pay $18.90 per share. Varex, a developer of X-ray sources and detectors, complements Teledyne's existing healthcare market presence, with the transaction expected to close in early 2027 pending regulatory and shareholder approvals.
Varex Imaging (VREX) swings to Q3 profit with margin gains and tariff refund boost
Varex Imaging (VREX) reported a swing to profit in Q3 fiscal 2026, with GAAP net income of $15.7 million compared to a significant loss a year prior. The company saw a 4% year-over-year increase in total revenue to $210.5 million, boosted by a $17 million U.S. Customs refund for IEEPA tariffs, which enhanced gross profit. Despite a decline in cash due to debt redemption and higher inventory, non-GAAP gross margin and diluted EPS improved, reflecting stronger underlying operational performance.
Teledyne to Acquire Varex Imaging Corporation
Teledyne Technologies Incorporated announced its definitive agreement to acquire Varex Imaging Corporation for $18.90 per share in cash, valuing the transaction at approximately $1.1 billion. Both companies' boards have unanimously approved the acquisition, which is expected to close in early 2027, subject to regulatory and stockholder approvals. The acquisition aims to combine Varex's expertise in X-ray sources and detectors with Teledyne's existing healthcare market presence, offering complementary product portfolios.
VREX Looks 11.5% Undervalued on GF Value™ as It Prepares Q3 Earnings
Varex Imaging Corp (VREX) is set to release its Q3 earnings on August 10, with analysts forecasting increased EPS and revenue. Despite facing profitability and cash flow challenges, the company appears 11.5% undervalued according to GuruFocus' GF Value™ metric, though this should be interpreted cautiously due to its loss-making status. Institutional investors show a nuanced confidence, with more gurus adding than trimming positions, while insider selling indicates some management cautiousness.
Teledyne Technologies to Buy Varex Imaging for $1.1 Billion
Teledyne Technologies has announced its intention to acquire Varex Imaging for $1.1 billion. This acquisition will expand Teledyne's portfolio in the imaging and sensing sector. The deal is subject to regulatory approvals and customary closing conditions.
Varex Imaging Corp (VREX) Stock News Today
This article provides current stock information for Varex Imaging Corp (VREX), including its latest stock price, market capitalization, and a note indicating that more news is coming soon. The stock closed at $12.410, up 1.31%, with a market cap of $523.04 million. It also lists various sections available for the stock, such as financials, stock score, and analyst ratings.
Varex Imaging Corp (VREX) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Varex Imaging Corp (VREX), highlighting its current earnings forecast score of 8.40 and ranking within the Healthcare Equipment & Supplies industry. It details analyst ratings, including an average price target of $18.00, and addresses FAQs regarding expected revenue, price targets, and past EPS performance. The article notes that most analysts recommend a "Buy" trend for VREX.
(VREX) Movement Within Algorithmic Entry Frameworks
This article provides an algorithmic analysis of Varex Imaging Corporation (NASDAQ: VREX), detailing strong near-term sentiment but neutral mid and long-term outlooks. It highlights an exceptional risk-reward setup targeting a 14.3% gain and outlines specific institutional trading strategies including long, breakout, and short positions with defined entry zones, targets, and stop losses. The analysis also presents multi-timeframe signal analysis with support and resistance levels.
Varex Imaging Corporation Revenue Breakdown – NASDAQ:VREX
Varex Imaging Corporation (VREX) generated a total revenue of $844.60 million USD last year. The Medical segment was its highest-performing, contributing $592.60 million USD, an increase from the previous year. The EMEA region was the largest contributor to revenue, accounting for $284.80 million USD.
Varex Imaging Corp (VREX) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Varex Imaging Corp (VREX), detailing its current price momentum score, support and resistance levels, and technical indicator readings. It shows that VREX has a price momentum score of 3.49 and is currently trading between resistance at 11.74 and support at 10.33, suitable for range-bound swing trading. The analysis includes a breakdown of various technical indicators and moving averages, with a summary signal of "Neutral" based on these metrics.
Varex Imaging Corp (VREX): Vanguard Capital Management discloses 5.1% ownership stake
Vanguard Capital Management LLC has disclosed a 5.1% beneficial ownership stake in Varex Imaging Corp (VREX), amounting to 2,147,586 common shares, through a Schedule 13G filing. The filing indicates that Vanguard has sole voting power over 280,424 shares and sole dispositive power over all 2,147,586 shares, with the ownership distributed across various Vanguard funds and managed accounts. No other single person holds more than a 5% interest within Vanguard's reported position.
Varex Imaging Corp (VREX) Institutional Confidence
Varex Imaging Corp (VREX) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 103.49%, showing a 6.87% increase quarter-over-quarter. Richard Pzena is the largest institutional shareholder, holding 4.15 million shares, which represents 9.52% of shares outstanding.
VREX|Varex Imaging Corp|Price:11.121|Chg%:-0.009
This analysis of Varex Imaging Corp (VREX) highlights stable fundamentals, high growth potential, and a fairly valued stock with significant institutional ownership. Analysts have rated it a "Buy" with a target price of $18.00, suggesting a 63.93% upside. The stock is currently trading sideways, making it suitable for range-bound swing trading, despite average recent market performance.
Varex Imaging Corporation Revenue Breakdown – BX:VI4
Varex Imaging Corporation (BX:VI4) generated 672.72 million CHF in revenue last year. The Medical segment was the top-performing segment, contributing 472.00 million CHF, while EMEA was the greatest regional contributor, accounting for 226.84 million CHF.
Press Release: Varex Schedules Third Quarter Fiscal Year 2026 Earnings Release and Conference Call
Varex Imaging Corporation has announced it will release its third-quarter fiscal year 2026 financial results after market close on Tuesday, August 6, 2026. This will be followed by a conference call at 5:00 p.m. ET (2:00 p.m. PT) to discuss the results and business outlook. Investors can access the live webcast or a replay through the company's investor relations website, and dial-in options are also provided.
Varex Imaging Corp (VREX) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of Varex Imaging Corp (VREX), noting its current valuation score of 8.87 and its ranking within the Healthcare Equipment & Supplies industry. It highlights the company's P/E ratio, comparing it to recent highs and lows, but also states that data for P/B, P/S, and P/CF ratios have not yet been disclosed by the company.
